We use cookies to ensure that we give you the best experience on our website. By continuing to use our site, you are agreeing to our use of cookies. You can change your cookie settings at any time if you want. Find out more in our privacy and cookies policy.
Find our statements and responses to events affecting people with cystic fibrosis (CF) here.
In this section
If you need to get in touch with our press team, please contact pressoffice@cysticfibrosis.org.uk or call on 020 3795 2193.
Letter to Petitions Committee from the Cystic Fibrosis Trust (11 June 2019)
Letter from David Ramsden, Chief Executive, to Dr Sarah Wollaston MP in response to NHS, NICE and Vertex correspondence (4 June 2019)
Statement on the NHS offer to Vertex for Orkambi and Symkevi (23 May 2019)
Letter from Ian Austin MP to Prime Minister Theresa May (16 May 2019)
Marking the anniversary of PM Theresa May wishing for a "speedy resolution" on Orkambi (16 May 2019)
Cystic Fibrosis Trust calls for immediate access to life-saving drugs (7 March 2019)
Creon shortage - Oxfordshire & Surrey (26 July 2018)
Mylan announces temporary Creon shortage (12 June 2018)
Cystic Fibrosis Trust appoints David Ramsden as new Chief Executive (12 October 2016)
The Cystic Fibrosis Trust's response to the NHS England decision that complex heart surgery should no longer be provided at the Royal Brompton & Harefield NHS Foundation Trust (8 July 2016).
The Cystic Fibrosis Trust's response to the NHS England funding decision for Ivacaftor (Kalydeco) for two to five year olds (4 August 2016).
The Cystic Fibrosis Trust's Safeguarding policy statement (November 2019)
The Trust is committed to funding and supporting cutting-edge research to find new and better treatments for cystic fibrosis. Take a look at some of that work and the progress that is being made.
Find out more about cystic fibrosis, its diagnosis and how it is treated, as well as useful links to our publications and other organisations who can help.
If you would like to find out more about any of our campaigns, publications or anything else, get in touch and we'll be happy to help.